| dc.citation.doi | 10.1016/j.clim.2014.04.018 | en_US |
| dc.citation.epage | 240 | en_US |
| dc.citation.issue | 1 | en_US |
| dc.citation.jtitle | Clinical Immunology | en_US |
| dc.citation.spage | 228 | en_US |
| dc.citation.volume | 153 | en_US |
| dc.contributor.author | Slone, Emily Archer | |
| dc.contributor.author | Fleming, Sherry D. | |
| dc.contributor.authoreid | sdflemin | en_US |
| dc.date.accessioned | 2015-05-18T11:46:37Z | |
| dc.date.available | 2015-05-18T11:46:37Z | |
| dc.date.issued | 2015-05-18 | |
| dc.date.published | 2014 | en_US |
| dc.description.abstract | Ischemia, lack of blood flow, and reperfusion, return of blood flow, is a common phenomenon affecting millions of Americans each year. Roughly 30,000 Americans per year experience intestinal ischemia-reperfusion (IR), which is associated with a high mortality rate. Previous studies of the intestine established a role for neutrophils, eicosanoids, the complement system and naturally occurring antibodies in IR-induced pathology. Furthermore, data indicate involvement of a lipid or lipid-like moiety in mediating IR-induced damage. It has been proposed that exposure of neo-antigens are recognized by antibodies, triggering action of the complement cascade. While it is evident that the pathophysiology of IR-induced injury is complex and multi-factorial, we focus this review on the involvement of eicosanoids, phospholipids and neo-antigens in the early pathogenesis. Lipid changes occurring in response to IR, neo-antigens exposed and the role of a phospholipid transporter, phospholipid scramblase 1 will be discussed. | en_US |
| dc.identifier.uri | http://hdl.handle.net/2097/19249 | |
| dc.language.iso | en_US | en_US |
| dc.relation.uri | http://www.sciencedirect.com/science/article/pii/S1521661614001260 | en_US |
| dc.rights | NOTICE: this is the author's version of a work that was accepted for publication in . Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Clinical Immunology, [153, 1, (2014)] 10.1016/j.clim.2014.04.018 | en_US |
| dc.subject | Ischemia | en_US |
| dc.subject | Reperfusion | en_US |
| dc.subject | Lipids | en_US |
| dc.subject | Neo-antigen | en_US |
| dc.title | Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury | en_US |
| dc.type | Article (author version) | en_US |
English
العربية
বাংলা
Català
Čeština
Deutsch
Ελληνικά
Español
فارسی
Suomi
Français
Gàidhlig
ગુજરાતી
हिंदी
Magyar
Italiano
Қазақ
Latviešu
मराठी
Nederlands
Polski
Português
Português do Brasil
Русский
Srpski (lat)
Српски
Svenska
தமிழ்
Türkçe
Yкраї́нська
Tiếng Việt
繁体中文